Feds helping Canadian cannabis firms grow their businesses

December 1st, 2017|Media|

The funding is especially useful for licensed cannabis producers with a focus on medical research, said Dr. Avtar Dhillon, executive director of Emerald Health Therapeutics, another B.C. licensed producer that has received backing from the council. Emerald used its funding [...]

10 Canadian Marijuana Stocks for Your Portfolio

November 15th, 2017|Media|

Emerald Health Therapeutics (OTC: EMHTF) is also a producer of dry cannabis and cannabis oils for medical use based out of British Columbia. New Cannabis Ventures reports that the company raised CAD 10 million in equity from Dundee Capital. Click [...]

Delta pot application looking good, says Emerald

November 14th, 2017|Media|

Emerald Health Therapeutics Inc. announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations has met the requirements of the paper-based review of Health Canada’s Office of [...]

TSX warns Canadian cannabis companies to cut U.S. ties

October 30th, 2017|Media|

While the TSX’s position could have serious consequences for some companies if those firms are forced to divest U.S. assets, Avtar Dhillon, Emerald Health’s executive chairman, said the clarification is good in the long run for Canadian companies. Click here [...]

How Leaders Can Adapt To An Environment Of Change

October 12th, 2017|Media|

It's a perfect storm of opportunity. With the opioid addiction crisis spiralling out of control, the medical community is desperate to find a new way to treat chronic pain. Most of all, society needs an inexpensive prescription painkiller that doesn't [...]